Atlas Trials

Early and Late Neutrophil CD64 and Monocyte HLA-DR as Biomarkers for Septic Shock

Clinical trial NCT07401329 · COMPLETED

Trial details

NCT number
NCT07401329
Sponsor
Pandit Bhagwat Dayal Sharma, PGIMS, Rohtak
Status
COMPLETED
Study type
OBSERVATIONAL
SepsisSeptic Shock
Start date
2019-01-05
Primary completion
2019-12-31
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.